£99.03

Springer Adult T-cell Leukemia/Lymphoma

Price data last checked 42 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£99 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 49 days · 49 data points (no recent data)

Historical
Generating forecast…
£99.03 £94.08 £96.06 £98.04 £100.02 £102.00 £103.98 25 April 2026 07 May 2026 19 May 2026 31 May 2026 12 June 2026

Price Distribution

Price distribution over 49 days • 1 price levels

Days at Price
49 days 0 12 25 37 49 £99 Days at Price

Price Analysis

Most common price: £99 (49 days, 100.0%)

Price range: £99 - £99

Price levels: 1 different prices over 49 days

Description

This book provides essential information on the epidemiology, molecular and genetic features, anti-CCR4 antibody therapy and a nationwide study of transplantation on human T-leukemia virus type-I (HTLV-1) and adult T-cell leukemia/lymphoma (ATL). This rare but important disease has restricted endemic areas and distinct clinical features such as a high frequency of hypercalcemia, strong predisposition to infection and poor response to chemotherapy, aspects which set ATL apart from other types of non-Hodgkin lymphoma. Given the small number of patients, enrollment in clinical trials has not been feasible, and establishing treatment standard has been difficult but new evidence, such as results of nationwide studies on transplantation, have shown new insights and potential treatments. Based on recent evidence, the book presents new treatment methods for ATL and infection prevention of HTLV-1, enabling clinicians, researchers and post-docs specializing in hematology and virology to gain a valuable overview of the disease.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

T-Cell Lymphomas (Contemporary Hematology)
97% match

T-Cell Lymphomas (Contemporary Hematology)

Humana

£80.66 02 Jul 2026
T-Cell and NK-Cell Lymphomas: From Biology to Novel Therapies: 176 (Cancer Treatment and Research, 176)
97% match

T-Cell and NK-Cell Lymphomas: From Biology to Novel Therapies: 176 (Cancer Treatment and Research, 176)

Springer

£107.85 24 Jul 2026
The Peripheral T-Cell Lymphomas
97% match

The Peripheral T-Cell Lymphomas

Wiley-Blackwell

£156.70 16 Jun 2026
Atlas of Clinical Hematology
97% match

Atlas of Clinical Hematology

Springer

£70.29 19 Jun 2026
Adult Acute Lymphocytic Leukemia: Biology and Treatment (Contemporary Hematology)
97% match

Adult Acute Lymphocytic Leukemia: Biology and Treatment (Contemporary Hematology)

Humana

£163.59 29 Jun 2026
Adult Acute Lymphocytic Leukemia: Biology and Treatment (Contemporary Hematology)
97% match

Adult Acute Lymphocytic Leukemia: Biology and Treatment (Contemporary Hematology)

Humana

£141.73 17 Jun 2026
Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)
96% match

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)

Springer

£430.64 13 Jun 2026
Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)
96% match

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)

Springer

£401.90 16 Jun 2026
Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)
96% match

Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)

Springer

£248.00 17 Jun 2026
Chronic Lymphocytic Leukemia: Pathobiology, B Cell Receptors, Novel Mutations, Clonal Evolution (Molecular and Translational Medicine)
96% match

Chronic Lymphocytic Leukemia: Pathobiology, B Cell Receptors, Novel Mutations, Clonal Evolution (Molecular and Translational Medicine)

Humana

£65.59 03 Jul 2026
CAR T-Cell, An Issue of Hematology/Oncology Clinics of North America: Volume 37-6 (The Clinics: Internal Medicine, Volume 37-6)
96% match

CAR T-Cell, An Issue of Hematology/Oncology Clinics of North America: Volume 37-6 (The Clinics: Internal Medicine, Volume 37-6)

Elsevier

£72.18 04 Jul 2026
Springer - Advances in Chronic Lymphocytic Leukemia, Vol 792
96% match

Springer - Advances in Chronic Lymphocytic Leukemia, Vol 792

Springer

£108.00 17 Jul 2026
Chronic Lymphoid Leukemias: 26 (Basic and Clinical Oncology)
96% match

Chronic Lymphoid Leukemias: 26 (Basic and Clinical Oncology)

CRC Press

£94.60 11 Jun 2026
Innovative Leukemia and Lymphoma Therapy: 35 (Basic and Clinical Oncology)
96% match

Innovative Leukemia and Lymphoma Therapy: 35 (Basic and Clinical Oncology)

CRC Press

£134.00 14 Jul 2026
Springer - New Agents for the Treatment of Acute Lymphoblastic Leukemia
96% match

Springer - New Agents for the Treatment of Acute Lymphoblastic Leukemia

Springer

£107.98 09 May 2026
Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)
96% match

Gene and Cellular Immunotherapy for Cancer (Cancer Drug Discovery and Development)

Humana

£106.78 26 Jun 2026
Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)
96% match

Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)

Springer

£150.48 13 May 2026
Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)
96% match

Immunoconjugate Therapy of Hematologic Malignancies: 68 (Cancer Treatment and Research, 68)

Springer

£179.99 13 Jul 2026
Springer - Transplantation in Hematology and Oncology II
96% match

Springer - Transplantation in Hematology and Oncology II

Springer

£129.64 15 Jul 2026
Leukemias
96% match

Leukemias

Springer

£76.41 15 Jul 2026
Acute Leukemias (Hematologic Malignancies)
96% match

Acute Leukemias (Hematologic Malignancies)

Springer

£103.69 16 Jun 2026
Humana Lymphoma: Methods and Protocols - Methods in Molecular Biology
96% match

Humana Lymphoma: Methods and Protocols - Methods in Molecular Biology

Humana

£101.39 15 Jul 2026
Atlas of Diagnostic Hematology
96% match

Atlas of Diagnostic Hematology

Elsevier

£154.16 16 Jun 2026
Springer - Transplantation in Hematology and Oncology II
96% match

Springer - Transplantation in Hematology and Oncology II

Springer

£108.00 15 Jul 2026